Alzheimer’s Association Health Services Research in Alzheimer’s Disease and Related Disorders (HSR-ADRD) Funding Program
Forecasted
Alzheimer’s Association’s HSR-ADRD Funding Program supports researchers studying dementia detection, diagnosis, and care pathways to build evidence for equitable, person-centered care.
Funder: Alzheimer's Association
Due Dates (Anticipated): May 2027 (Letter of Intent) | July 2027 (Full application)
Funding Amounts: Up to US$250,000, including direct and indirect costs, for one to two years
Summary: Supports health services research improving dementia detection, diagnosis, and post-diagnostic care through actionable evidence for equitable, person-centered care.
Key Information: Full applications require an approved Letter of Intent from the current cycle and an invitation to apply.
Description
The Alzheimer's Association administers this program through its William and Sheila Konar Health Services Research Initiative, with support from the William and Sheila Konar Foundation. It funds rigorous, innovative research on how dementia care is delivered, accessed, financed, and experienced. The goal is actionable evidence that improves timely access, quality, coordination, and equity across communities and healthcare settings.
Proposals must address early detection and diagnosis or care pathways for people with mild cognitive impairment (MCI) or dementia. Early detection studies examine outcomes across at least two levels of the dementia care ecosystem. Care pathway studies consider comorbidities, screening and diagnosis in different settings, and post-diagnosis treatment, including pharmacological and non-pharmacological approaches. Innovative methods, community voices, intersectional frameworks, and scalable, sustainable solutions are particularly aligned with the program.
